Contract Development and Manufacturing Outsourcing Models

Report Overview

It is no surprise that with only one-third of pharmaceutical manufacturing conducted in house, the practice of outsourcing manufacturing activities has evolved over the past 25 years and continues to do so. ISR’s Contract Development and Manufacturing Outsourcing Models report takes an in-depth look at current outsourcing practices among drug innovators to gain insight into the adoption and application of different outsourcing strategies. This report explores how sponsor organizations use contract manufacturers through various outsourcing models, including Tactical or Transactional Outsourcing, Preferred Providers and Strategic Partnerships to streamline costs, better manage capacity, improve efficiencies and decrease time to market.

How you can use this report:

For drug developers:

• Benefits and drawbacks of using each of three different outsourcing models for development and/or commercial manufacturing needs
• Understand the cost breakdown of an outsourced manufacturing project by molecule type and stage of development to identify areas where potential savings may be gained
• How to prepare for challenges and difficulties that peers have encountered when using contract manufacturers through various outsourcing models

For contract manufacturers:

• Gain insight into how sponsor experience and capacity influence outsourcing strategies as well as which drug products and components are most likely to be outsourced
• Learn decision-making hierarchies and outsourcing drivers influencing CMO selection then use this information to improve your sales pitch and approach
• Use this report to plan for changes in outsourcing model usage, to understand why those changes may transpire and to capture new business by zeroing in on the elements that drive an outsourcing model’s success